Skip to content

Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

Efficacy of Dextrose 5% in Comparison With Steroid in Median Nerve Ultrasound Guided Hydrodissection in Patients With Carpal Tunnel Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05725460
Enrollment
40
Registered
2023-02-13
Start date
2023-02-01
Completion date
2023-09-13
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Brief summary

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Detailed description

in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks

Interventions

PROCEDUREdextrose 5% median nerve hydrodissection

planned to be a good alternative to steroid hydrodissection

Sponsors

Iraqi Board of medical specialties
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

2 groups comparing the efficacy of dextrose water 5 % in median nerve hydrodissection

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

severe carpal tunnel syndrome failed medical management -

Exclusion criteria

previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus \-

Design outcomes

Primary

MeasureTime frameDescription
pain relief in 2 weeks follow up6 monthsdifference in sensory and functional symptoms post median nerve hydrodissection using dextrose and compare this effect with steroid population arm using Boston questionnaire

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026